# Edward Chia‐Cheng Lai

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/edward-chia-cheng-lai/

## Facts

| Field | Value |
| --- | --- |
| Citations | 6,003 |
| Field | Diabetes Treatment and Management |
| h-index | 37 |
| i10-index | 109 |
| Last Known Institution | American Association of Colleges of Pharmacy |
| OpenAlex ID | https://openalex.org/A5037135870 |
| ORCID iD | 0000-0002-5852-7652 |
| Works | 252 |

## Researcher papers

- [&lt;p&gt;Taiwan’s National Health Insurance Research Database: past and future&lt;/p&gt;](https://scholariq.org/papers/and-lt-p-and-gt-taiwan-s-national-health-insurance-research-database-past-and/)
- [Global Epidemiology of Hip Fractures: Secular Trends in Incidence Rate, Post‐Fracture Treatment, and All‐Cause Mortality](https://scholariq.org/papers/global-epidemiology-of-hip-fractures-secular-trends-in-incidence-rate-post/)
- [The Chang Gung Research Database—A multi‐institutional electronic medical records database for real‐world epidemiological studies in Taiwan](https://scholariq.org/papers/the-chang-gung-research-database-a-multi-institutional-electronic-medical/)
- [Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases](https://scholariq.org/papers/trends-in-attention-deficit-hyperactivity-disorder-medication-use-a/)
- [Use of the landmark method to address immortal person-time bias in comparative effectiveness research: a simulation study](https://scholariq.org/papers/use-of-the-landmark-method-to-address-immortal-person-time-bias-in-comparative/)
- [Management of Acute Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Utilizing Amniotic Membrane and Topical Corticosteroids](https://scholariq.org/papers/management-of-acute-stevens-johnson-syndrome-and-toxic-epidermal-necrolysis/)
- [Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies](https://scholariq.org/papers/sequence-symmetry-analysis-in-pharmacovigilance-and-pharmacoepidemiologic/)
- [Comparative risk evaluation for cardiovascular events associated with dapagliflozin vs. empagliflozin in real-world type 2 diabetes patients: a multi-institutional cohort study](https://scholariq.org/papers/comparative-risk-evaluation-for-cardiovascular-events-associated-with/)
- [Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study](https://scholariq.org/papers/incidence-of-type-2-diabetes-mellitus-in-men-receiving-steroid-5-reductase/)
- [The Asian Pharmacoepidemiology Network (AsPEN): promoting multi‐national collaboration for pharmacoepidemiologic research in Asia](https://scholariq.org/papers/the-asian-pharmacoepidemiology-network-aspen-promoting-multi-national/)
- [Comparative anatomical outcomes of high-flow vs. low-flow phacoemulsification cataract surgery: A systematic review and meta-analysis](https://scholariq.org/papers/comparative-anatomical-outcomes-of-high-flow-vs-low-flow-phacoemulsification/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)
- [Pharmacovigilance and Adverse Drug Reactions](https://scholariq.org/topics/pharmacovigilance-and-adverse-drug-reactions/)
- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)
- [Pharmaceutical Practices and Patient Outcomes](https://scholariq.org/topics/pharmaceutical-practices-and-patient-outcomes/)

## Researcher university

- [American Association of Colleges of Pharmacy](https://scholariq.org/institutions/american-association-of-colleges-of-pharmacy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
